TG THERAPEUTICS, INC. TGTX
TG THERAPEUTICS, INC. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 11,388,346 | $202.6M | 7.06% |
| D. E. Shaw & Co., Inc. | 3,478,508 | $191.1M | 2.16% |
| TWO SIGMA INVESTMENTS, LP | 2,506,871 | $137.7M | 1.55% |
| CITADEL ADVISORS LLC | 1,240,670 | $68.2M | 0.77% |
| RENAISSANCE TECHNOLOGIES LLC | 679,300 | $37.3M | 0.42% |
| AQR CAPITAL MANAGEMENT LLC | 442,287 | $24.3M | 0.27% |
| Bridgewater Associates, LP | 429,904 | $23.6M | 0.27% |
| Point72 Asset Management, L.P. | 367,163 | $20.2M | 0.23% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.